ArticleJournal of personalized medicine2022

Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants.

Oleksandr Oliynyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.